Company News
Gland Pharma FY26 Business Responsibility Sustainability Report
Gland Pharma submitted its standalone Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 to BSE and NSE in compliance with SEBI LODR Regulation 34(2)(f).
The company reported 4,29
